What is ISRG stock price target for 2026?

WallStSmart's 12-month price target for Intuitive Surgical Inc is $236.79, representing 48.3% downside from the current price of $457.61.

What is ISRG stock forecast?

Intuitive Surgical Inc forecast includes bull, base, and bear case scenarios from 2026 through 2030. Revenue and EPS projections are derived from analyst consensus and conservative extrapolation with growth deceleration for outer years.

Is ISRG undervalued based on price targets?

Our DCF intrinsic value for Intuitive Surgical Inc is $1,954.79, against a current price of $457.61. The margin of safety is 76.59%.

ISRG

Intuitive Surgical Inc

NASDAQ: ISRG · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$457.61

+0.83% today

Updated 2026-04-30

Market cap

$160.73B

P/E ratio

55.28

P/S ratio

15.19x

EPS (TTM)

$8.21

Dividend yield

—

52W range

$428 – $604

Volume

1.9M

Market cap

$160.73B

P/E ratio

55.28

P/S ratio

15.19x

EPS (TTM)

$8.21

Dividend yield

—

52W range

$428 – $604

Volume

1.9M

Intuitive Surgical Inc (ISRG) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

Price target summary

Current

$457.61

Consensus

$611.00

+33.52%

2030 Target

$632.90

+38.31%

DCF

$1,954.79

+76.59% MoS

Current price

$457.61

Analyst consensus

$611.00

+33.52%

2030 Target

$632.90

+38.31%

Intrinsic (DCF)

$1,954.79

+76.59% MoS

16 analysts:

7 Buy3 Hold2 Sell

Management guidance

No specific CEO revenue targets for 2026-2030 found in available data. Management focused on da Vinci 5 launch with 10,000x computing power increase and expansion in Europe. Guidance implies continued procedure volume growth and instrument attach rate expansion, but no quantified revenue targets disclosed.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

Revenue & price projection

Actual revenue Projected revenue Base case Bull to bear range

Bull case (2030)

$1,084.97

$19.8B Rev × 20x P/S

Base case (2030)

$632.90

$19.8B Rev × 12x P/S

Bear case (2030)

$452.07

$19.8B Rev × 8x P/S

Financial forecast — research-backed

Metric	2023	2024	2025	2026 (E)	2027 (E)	2028 (E)	2029 (E)	2030 (E)
Revenue	$7.1B	$8.4B	$10.1B	$11.8B	$13.4B	$15.2B	$17.4B	$19.8B
Revenue growth	—	17.2%	20.5%	16.8%	13.9%	13.9%	14.0%	14.0%
EPS	$5.71	$7.33	$8.93	$10.22	$11.68	$13.25	$15.10	$17.20
P/S ratio	—	—	—	12.0x	12.0x	12.0x	12.0x	12.0x
Implied price	—	—	—	$406.86	$452.07	$497.28	$587.69	$632.90

Catalysts & risks

Growth catalysts

+ da Vinci 5 system adoption acceleration with AI/ML capabilities and force sensing

+ European market expansion through direct distribution operations acquisition

+ Procedure volume growth from aging population and surgical robotic penetration increase

+ Instrument and consumable attach rate expansion from larger installed base

+ Emerging markets (particularly Asia ex-China) penetration with localized pricing

Key risks

- Intensifying competition in China from local robotic suppliers with provincial tender wins declining

- Valuation compression risk given 59.2x P/E and premium multiples vs. historical averages

- Regulatory scrutiny on medical device pricing and reimbursement pressures

- Execution risk on da Vinci 5 adoption rates and technology transition

- Cybersecurity incidents (recent phishing attack) impacting operational continuity

Methodology

Intuitive Surgical Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 16 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.